US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bristol-Myers Squibb

47.92

-0.5100-1.05%

Post-market: 47.960.0400+0.08%19:55 EDT

Volume:11.61M

Turnover:558.63M

Market Cap:97.54B

PE:19.28

High:49.11

Open:48.84

Low:47.72

Close:48.43

52wk High:63.33

52wk Low:42.96

Shares:2.04B

Float Shares:2.03B

Volume Ratio:1.24

T/O Rate:0.57%

Dividend:2.46

Dividend Rate:5.13%

EPS(TTM):2.49

EPS(LYR):-4.4144

ROE:29.32%

ROA:8.34%

PB:5.59

PE(LYR):-10.86

Loading ...

Overview Company News Filings

Cantor Fitzgerald Adjusts Price Target on Bristol-Myers Squibb to $45 From $55, Maintains Neutral Rating

MT Newswires Live

Evotec SE Reports H1 2025 Results: Consolidated Revenues Down 5% to €371.2M, Adjusted EBITDA at -€1.9M, Just - Evotec Biologics Sales Up 16%

Editas Medicine's CD19 HD Allo CAR T Program Receives IND/CTA Acceptance, Secures Milestone Payment Through Collaboration with Bristol Myers Squibb

Bloomsbury Executives Sell Shares Post-Vesting to Cover Liabilities

Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog

MT Newswires Live

Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler

Bloomsbury Publishing Announces Share Awards Vesting

4 Stocks That Deliver the Coveted 5% Yield -- Barron's

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Prothena Corporation Unveils Presentation on Life-Saving Therapies for Protein Dysregulation Diseases

Bristol-Myers Squibb Files Initial Ownership Statement for EVP Cristian Massacesi

Wendy Short Bartie, EVP of Corporate Affairs, Reports Disposal of Common Shares in Bristol-Myers Squibb Company

Daiwa Securities Downgrades Bristol-Myers Squibb to Neutral From Outperform, Adjusts PT to $42 From $60

MT Newswires Live

Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day

Prothena Corporation plc Unveils Presentation Highlighting Advances in Life-Saving Therapies for Neurodegenerative Diseases

Bristol Myers Squibb's Breyanzi CAR T Cell Therapy for Marginal Zone Lymphoma Under Priority Review by FDA

Bristol-Myers Squibb Co - FDA Sets Pdufa Goal Date for Breyanzi on Dec 5, 2025

THOMSON REUTERS

Bristol Myers Squibb’s Application for Breyanzi (Lisocabtagene Maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (Mzl)

THOMSON REUTERS

Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction

Bristol-Myers Squibb’s New Phase 3 Trial: A Potential Game-Changer in Lung Cancer Treatment?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BMY/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","market":"US","secType":"STK","nameCN":"Bristol-Myers Squibb","latestPrice":47.92,"timestamp":1755892800000,"preClose":48.43,"halted":0,"volume":11609088,"hourTrading":{"tag":"盘后","latestPrice":47.96,"preClose":47.92,"latestTime":"19:55 EDT","volume":274583,"amount":13158313.2013,"timestamp":1755906945108},"delay":0,"floatShares":2031646263,"shares":2035435838,"eps":2.485967,"marketStatus":"Not Yet Opened","change":-0.51,"latestTime":"08-22 16:00:00 EDT","open":48.84,"high":49.11,"low":47.72,"amount":558625251.3792,"amplitude":0.028701,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.485967,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1756108800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":-18475200000,"exchange":"NYSE","adjPreClose":48.43,"dividendRate":0.051336,"preHourTrading":{"tag":"盘前","latestPrice":48.81,"preClose":48.43,"latestTime":"09:25 EDT","volume":1476,"amount":71830.711944,"timestamp":1755869106349},"postHourTrading":{"tag":"盘后","latestPrice":47.96,"preClose":47.92,"latestTime":"19:55 EDT","volume":274583,"amount":13158313.2013,"timestamp":1755906945108},"volumeRatio":1.241782254165749,"impliedVol":0.2895,"impliedVolPercentile":0.2651},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMY\",,,,,undefined,":{"symbol":"BMY","floatShares":2031646263,"roa":"8.34%","roe":"29.32%","lyrEps":-4.414405,"volumeRatio":1.241782254165749,"shares":2035435838,"dividePrice":2.46,"high":49.11,"amplitude":0.028701,"preClose":48.43,"low":47.72,"week52Low":42.96,"pbRate":"5.59","psRate":"2.04","week52High":63.33,"institutionHeld":0.7058,"latestPrice":47.92,"eps":2.485967,"divideRate":0.051336,"volume":11609088,"delay":0,"ttmEps":2.485967,"open":48.84,"prevYearClose":56.56,"prevWeekClose":48.44,"prevMonthClose":43.31,"prevQuarterClose":46.29,"fiveDayClose":48.44,"twentyDayClose":48.43,"sixtyDayClose":46.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-07-31","symbol":"BMY","fiscalQuarterEnding":"2025/06","expectedEps":1.07,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":1.46},{"date":"2025-07-03","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-03","defaultRemindTime":1751549400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-01","payableDate":"2025-07-03","currency":"USD","dateTimestamp":1751515200000,"payDate":"2025-08-01"},{"market":"US","date":"2025-04-24","symbol":"BMY","fiscalQuarterEnding":"2025/03","expectedEps":1.51,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745467200000,"reportTimeType":"pre","actualEps":1.8},{"date":"2025-04-04","symbol":"BMY","amount":0.62,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-04-04","defaultRemindTime":1743773400000,"name":"施贵宝","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-05-01","payableDate":"2025-04-04","currency":"USD","dateTimestamp":1743739200000,"payDate":"2025-05-01"},{"market":"US","date":"2025-02-06","symbol":"BMY","fiscalQuarterEnding":"2024/12","expectedEps":1.46,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738818000000,"reportTimeType":"pre","actualEps":1.67}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMY\",market:\"US\",,,undefined,":[{"executeDate":"2015-09-30","recordDate":"2015-10-02","paymentDate":"2015-11-02","value":0.37,"currency":"USD"},{"executeDate":"2015-12-30","recordDate":"2016-01-04","paymentDate":"2016-02-01","value":0.38,"currency":"USD"},{"executeDate":"2016-03-30","recordDate":"2016-04-01","paymentDate":"2016-05-02","value":0.38,"currency":"USD"},{"executeDate":"2016-06-29","recordDate":"2016-07-01","paymentDate":"2016-08-01","value":0.38,"currency":"USD"},{"executeDate":"2016-10-05","recordDate":"2016-10-07","paymentDate":"2016-11-01","value":0.38,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1034,"buy":0.1379,"hold":0.6897,"sell":0.069,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.6897,"analysts":29,"updateTime":1754366400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BMY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BMY","date":"2025-08-22","current":19.523897,"percent":0.741463,"low":-3427.632189,"twenty":-24.0554,"median":12.220826,"eighty":22.400619,"high":27.240851,"avg":-167.398133,"sd":700.354162,"marketCap":98576157634},"quantilePoints":[{"date":"2020-08-28","current":-249.694322,"twenty":24.53695,"median":43.30835,"eighty":63.241479,"marketCap":140577903184},{"date":"2020-09-04","current":-240.006006,"twenty":24.217273,"median":43.30835,"eighty":63.241479,"marketCap":135123381368},{"date":"2020-09-11","current":-236.162707,"twenty":23.958745,"median":43.30835,"eighty":63.241479,"marketCap":132959604118},{"date":"2020-09-18","current":-237.283669,"twenty":23.923139,"median":43.30835,"eighty":63.241479,"marketCap":133590705816},{"date":"2020-09-25","current":-238.164425,"twenty":23.703169,"median":43.30835,"eighty":63.241479,"marketCap":134086571436},{"date":"2020-10-02","current":-235.081779,"twenty":23.363915,"median":43.30835,"eighty":63.241479,"marketCap":132351041767},{"date":"2020-10-09","current":-247.492432,"twenty":17.593463,"median":43.30835,"eighty":63.241479,"marketCap":139338239135},{"date":"2020-10-16","current":-245.170439,"twenty":17.05085,"median":43.30835,"eighty":63.241479,"marketCap":138030957047},{"date":"2020-10-23","current":-240.726625,"twenty":16.915253,"median":43.30835,"eighty":63.241479,"marketCap":135529089602},{"date":"2020-10-30","current":-234.000852,"twenty":16.878905,"median":43.30835,"eighty":63.241479,"marketCap":131742479415},{"date":"2020-11-06","current":-3276.639701,"twenty":16.797113,"median":43.30835,"eighty":63.241479,"marketCap":144172146848},{"date":"2020-11-13","current":-3267.395263,"twenty":16.644024,"median":43.30835,"eighty":63.241479,"marketCap":143765391575},{"date":"2020-11-20","current":-3164.165705,"twenty":16.603263,"median":43.30835,"eighty":63.241479,"marketCap":139223291023},{"date":"2020-11-27","current":-3238.121209,"twenty":16.551974,"median":43.30835,"eighty":63.241479,"marketCap":142477333209},{"date":"2020-12-04","current":-3200.116297,"twenty":16.449584,"median":43.30835,"eighty":63.241479,"marketCap":140805117086},{"date":"2020-12-11","current":-3118.457095,"twenty":16.271128,"median":43.30835,"eighty":63.241479,"marketCap":137212112172},{"date":"2020-12-18","current":-3241.716269,"twenty":16.177691,"median":43.24944,"eighty":63.241479,"marketCap":142635515816},{"date":"2020-12-24","current":-3140.54103,"twenty":15.969441,"median":43.24944,"eighty":63.241479,"marketCap":138183805325},{"date":"2020-12-31","current":-3185.73606,"twenty":15.745139,"median":43.24944,"eighty":63.241479,"marketCap":140172386661},{"date":"2021-01-08","current":-3209.360735,"twenty":15.520794,"median":43.24944,"eighty":63.241479,"marketCap":141211872359},{"date":"2021-01-15","current":-3417.360591,"twenty":15.454453,"median":43.24944,"eighty":63.241479,"marketCap":150363866007},{"date":"2021-01-22","current":-3315.671773,"twenty":15.292279,"median":43.24944,"eighty":63.241479,"marketCap":145889558002},{"date":"2021-01-29","current":-3154.921267,"twenty":15.193414,"median":43.24944,"eighty":63.241479,"marketCap":138816535750},{"date":"2021-02-05","current":-15.270556,"twenty":15.111639,"median":43.24944,"eighty":63.241479,"marketCap":137664062476},{"date":"2021-02-12","current":-14.909163,"twenty":15.037512,"median":43.24944,"eighty":63.241479,"marketCap":134406104428},{"date":"2021-02-19","current":-15.060765,"twenty":14.994264,"median":43.24944,"eighty":63.241479,"marketCap":135772794271},{"date":"2021-02-26","current":-15.24219,"twenty":14.895142,"median":43.24944,"eighty":63.241479,"marketCap":137408341133},{"date":"2021-03-05","current":-15.018515,"twenty":14.827729,"median":43.252713,"eighty":64.853776,"marketCap":135391913495},{"date":"2021-03-12","current":-15.070706,"twenty":14.750073,"median":43.252713,"eighty":64.853776,"marketCap":135862413277},{"date":"2021-03-19","current":-15.582672,"twenty":14.671279,"median":43.252713,"eighty":64.853776,"marketCap":140477792093},{"date":"2021-03-26","current":-15.84441,"twenty":14.611498,"median":43.24944,"eighty":63.241479,"marketCap":142837352227},{"date":"2021-04-01","current":-15.59413,"twenty":14.591649,"median":43.24944,"eighty":63.241479,"marketCap":140581085012},{"date":"2021-04-09","current":-15.514834,"twenty":14.520487,"median":43.252713,"eighty":64.853776,"marketCap":139866228072},{"date":"2021-04-16","current":-16.221067,"twenty":14.424522,"median":43.252713,"eighty":64.853776,"marketCap":146232922690},{"date":"2021-04-23","current":-16.357358,"twenty":14.234366,"median":43.246167,"eighty":64.853776,"marketCap":147461583055},{"date":"2021-04-30","current":-22.411016,"twenty":14.031315,"median":41.99272,"eighty":64.853776,"marketCap":139374107187},{"date":"2021-05-07","current":-23.136268,"twenty":13.765653,"median":40.725784,"eighty":64.853776,"marketCap":143884451572},{"date":"2021-05-14","current":-23.294244,"twenty":13.598846,"median":40.216454,"eighty":64.853776,"marketCap":144866902824},{"date":"2021-05-21","current":-24.073352,"twenty":13.387812,"median":39.861196,"eighty":64.853776,"marketCap":149712173772},{"date":"2021-05-28","current":-23.595834,"twenty":13.305536,"median":39.584885,"eighty":64.853776,"marketCap":146742491578},{"date":"2021-06-04","current":-23.315786,"twenty":13.183703,"median":39.110931,"eighty":64.853776,"marketCap":145000873449},{"date":"2021-06-11","current":-24.177472,"twenty":13.076111,"median":38.321748,"eighty":64.853776,"marketCap":150359698461},{"date":"2021-06-18","current":-23.865111,"twenty":12.918943,"median":37.341182,"eighty":64.853776,"marketCap":148417124394},{"date":"2021-06-25","current":-23.962051,"twenty":12.713253,"median":37.032625,"eighty":64.853776,"marketCap":149019992208},{"date":"2021-07-02","current":-24.037448,"twenty":12.656819,"median":36.735495,"eighty":64.853776,"marketCap":149488889397},{"date":"2021-07-09","current":-24.112846,"twenty":12.542371,"median":36.569788,"eighty":64.853776,"marketCap":149957786585},{"date":"2021-07-16","current":-24.163111,"twenty":12.276028,"median":36.398367,"eighty":64.853776,"marketCap":150270384711},{"date":"2021-07-23","current":-24.536508,"twenty":12.058207,"median":36.20409,"eighty":64.853776,"marketCap":152592542216},{"date":"2021-07-30","current":-29.693807,"twenty":11.96591,"median":36.009813,"eighty":61.057,"marketCap":150814846842},{"date":"2021-08-06","current":-29.803185,"twenty":-14.753585,"median":35.906961,"eighty":60.876911,"marketCap":151370375230},{"date":"2021-08-13","current":-29.536304,"twenty":-14.987324,"median":35.781252,"eighty":60.876911,"marketCap":150014885963},{"date":"2021-08-20","current":-30.275696,"twenty":-15.059273,"median":34.627419,"eighty":60.876911,"marketCap":153770257867},{"date":"2021-08-27","current":-29.138169,"twenty":-15.115938,"median":34.17561,"eighty":60.876911,"marketCap":147992762629},{"date":"2021-09-03","current":-28.705034,"twenty":-15.248154,"median":33.35279,"eighty":60.876911,"marketCap":145792870212},{"date":"2021-09-10","current":-27.62001,"twenty":-15.348311,"median":32.979745,"eighty":60.876911,"marketCap":140282028600},{"date":"2021-09-17","current":-26.823741,"twenty":-15.441509,"median":32.518541,"eighty":60.876911,"marketCap":136237781934},{"date":"2021-09-24","current":-26.35123,"twenty":-15.542928,"median":32.364263,"eighty":60.876911,"marketCap":133837899297},{"date":"2021-10-01","current":-26.036223,"twenty":-15.613954,"median":32.061419,"eighty":60.876911,"marketCap":132237977539},{"date":"2021-10-08","current":-25.051826,"twenty":-15.777999,"median":31.581441,"eighty":60.876911,"marketCap":127238222044},{"date":"2021-10-15","current":-25.533087,"twenty":-16.234944,"median":30.750116,"eighty":60.876911,"marketCap":129682546953},{"date":"2021-10-22","current":-25.200579,"twenty":-16.36727,"median":30.429194,"eighty":60.876911,"marketCap":127993740652},{"date":"2021-10-29","current":-23.982843,"twenty":-22.664495,"median":30.34167,"eighty":60.876911,"marketCap":129627264204},{"date":"2021-11-05","current":-24.414041,"twenty":-23.13914,"median":30.156897,"eighty":60.876911,"marketCap":131957891385},{"date":"2021-11-12","current":-24.405828,"twenty":-23.227463,"median":30.035336,"eighty":60.876911,"marketCap":131913498487},{"date":"2021-11-19","current":-23.748763,"twenty":-23.330148,"median":29.933224,"eighty":60.876911,"marketCap":128362066591},{"date":"2021-11-26","current":-23.214899,"twenty":-23.393674,"median":29.797076,"eighty":60.876911,"marketCap":125476528175},{"date":"2021-12-03","current":-23.128659,"twenty":-23.393674,"median":29.729002,"eighty":60.876911,"marketCap":125010402739},{"date":"2021-12-10","current":-23.145086,"twenty":-23.461298,"median":29.636615,"eighty":60.876911,"marketCap":125099188536},{"date":"2021-12-17","current":-25.280544,"twenty":-23.568548,"median":27.951968,"eighty":60.876911,"marketCap":136641342198},{"date":"2021-12-23","current":-25.48177,"twenty":-23.634806,"median":27.65765,"eighty":60.876911,"marketCap":137728968216},{"date":"2021-12-31","current":-25.60497,"twenty":-23.766579,"median":27.039995,"eighty":60.876911,"marketCap":138394861697},{"date":"2022-01-07","current":-25.802089,"twenty":-23.903887,"median":26.592299,"eighty":60.865513,"marketCap":139460291266},{"date":"2022-01-14","current":-26.664486,"twenty":-23.969949,"median":26.503175,"eighty":60.865513,"marketCap":144121545629},{"date":"2022-01-21","current":-26.093661,"twenty":-24.000827,"median":26.434777,"eighty":60.865513,"marketCap":141036239169},{"date":"2022-01-28","current":-26.656272,"twenty":-24.081403,"median":26.28969,"eighty":60.865513,"marketCap":144077152730},{"date":"2022-02-04","current":20.625497,"twenty":-24.122181,"median":26.107856,"eighty":60.865513,"marketCap":144254724325},{"date":"2022-02-11","current":20.843465,"twenty":-24.122181,"median":25.804687,"eighty":60.865513,"marketCap":145779193401},{"date":"2022-02-18","current":21.052274,"twenty":-24.122181,"median":24.80247,"eighty":60.865513,"marketCap":147239600991},{"date":"2022-02-25","current":21.441842,"twenty":-24.122181,"median":24.575651,"eighty":60.865513,"marketCap":149964242016},{"date":"2022-03-04","current":21.616368,"twenty":-24.122181,"median":24.306674,"eighty":60.865513,"marketCap":151184881195},{"date":"2022-03-11","current":21.463658,"twenty":-24.122181,"median":23.979644,"eighty":60.865513,"marketCap":150116821913},{"date":"2022-03-18","current":22.133715,"twenty":-24.122181,"median":23.933202,"eighty":60.865513,"marketCap":154803204476},{"date":"2022-03-25","current":22.26692,"twenty":-24.122181,"median":23.737758,"eighty":60.865513,"marketCap":155734841105},{"date":"2022-04-01","current":22.431005,"twenty":-24.122181,"median":23.392104,"eighty":60.865513,"marketCap":156882450469},{"date":"2022-04-08","current":23.631255,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":165277000447},{"date":"2022-04-14","current":23.552252,"twenty":-24.122181,"median":23.0415,"eighty":60.865513,"marketCap":164724447790},{"date":"2022-04-22","current":23.017457,"twenty":-24.122181,"median":22.955165,"eighty":60.865513,"marketCap":160984091344},{"date":"2022-04-29","current":25.636645,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160254667678},{"date":"2022-05-06","current":26.113479,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":163235357657},{"date":"2022-05-13","current":25.817161,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":161383071741},{"date":"2022-05-20","current":25.949993,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162213406807},{"date":"2022-05-27","current":25.932963,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":162106953593},{"date":"2022-06-03","current":25.602585,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":160041761251},{"date":"2022-06-10","current":25.575338,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":159871436109},{"date":"2022-06-17","current":25.125751,"twenty":-24.122181,"median":22.930856,"eighty":60.865513,"marketCap":157061071271},{"date":"2022-06-24","current":26.893443,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":168110914838},{"date":"2022-07-01","current":26.17138,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":163597298583},{"date":"2022-07-08","current":25.674111,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160488864747},{"date":"2022-07-15","current":25.766071,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161063712101},{"date":"2022-07-22","current":24.846463,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":155315238569},{"date":"2022-07-29","current":23.80824,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":157539125557},{"date":"2022-08-05","current":23.272571,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":153994601994},{"date":"2022-08-12","current":24.385859,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":161361232290},{"date":"2022-08-19","current":24.308413,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":160848771052},{"date":"2022-08-26","current":22.972467,"twenty":-24.131516,"median":22.892874,"eighty":60.876911,"marketCap":152008814698},{"date":"2022-09-02","current":22.139921,"twenty":-24.131516,"median":22.294813,"eighty":60.876911,"marketCap":146499856390},{"date":"2022-09-09","current":22.640094,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":149809501885},{"date":"2022-09-16","current":23.078956,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":152713448900},{"date":"2022-09-23","current":22.817575,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":150983892222},{"date":"2022-09-30","current":22.940198,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":151795289182},{"date":"2022-10-07","current":22.491656,"twenty":-24.131516,"median":22.251727,"eighty":60.876911,"marketCap":148827284512},{"date":"2022-10-14","current":22.788532,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":150791719257},{"date":"2022-10-21","current":23.301613,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":154186774959},{"date":"2022-10-28","current":25.54071,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":170535320356},{"date":"2022-11-04","current":26.188951,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174863627979},{"date":"2022-11-11","current":25.251495,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":168604229262},{"date":"2022-11-18","current":25.746817,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":171911500215},{"date":"2022-11-25","current":26.34187,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":175884664649},{"date":"2022-12-02","current":26.970165,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":180079793576},{"date":"2022-12-09","current":26.205573,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":174974610226},{"date":"2022-12-16","current":24.430389,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":163121706273},{"date":"2022-12-23","current":24.23093,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":161789919312},{"date":"2022-12-30","current":23.918444,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":159703453073},{"date":"2023-01-06","current":24.267497,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":162034080255},{"date":"2023-01-13","current":24.104606,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160946454236},{"date":"2023-01-20","current":24.649794,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":164586671930},{"date":"2023-01-27","current":24.08466,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":160813275540},{"date":"2023-02-03","current":26.118629,"twenty":-24.131516,"median":22.245911,"eighty":60.876911,"marketCap":165252565410},{"date":"2023-02-10","current":25.329282,"twenty":-24.131516,"median":22.245911,"eighty":60.555486,"marketCap":160258364307},{"date":"2023-02-17","current":23.588424,"twenty":-24.131516,"median":22.245911,"eighty":60.138319,"marketCap":149243959795},{"date":"2023-02-24","current":23.279927,"twenty":-24.131516,"median":22.245911,"eighty":59.828291,"marketCap":147292098136},{"date":"2023-03-03","current":22.988016,"twenty":-24.131516,"median":22.245911,"eighty":59.303982,"marketCap":145445175275},{"date":"2023-03-10","current":21.79715,"twenty":-24.131516,"median":22.190955,"eighty":58.624659,"marketCap":137910569514},{"date":"2023-03-17","current":22.069158,"twenty":-24.131516,"median":22.143065,"eighty":57.674063,"marketCap":139631565816},{"date":"2023-03-24","current":22.499062,"twenty":-24.131516,"median":22.143065,"eighty":57.089646,"marketCap":142351566870},{"date":"2023-03-31","current":23.040928,"twenty":-24.122181,"median":22.147947,"eighty":56.818785,"marketCap":145779951237},{"date":"2023-04-06","current":23.210469,"twenty":-24.122181,"median":22.147947,"eighty":56.570827,"marketCap":146852635917},{"date":"2023-04-14","current":23.499685,"twenty":-24.131516,"median":22.143065,"eighty":54.708084,"marketCap":148682509782},{"date":"2023-04-21","current":23.114063,"twenty":-24.131516,"median":22.143065,"eighty":52.238402,"marketCap":146242677962},{"date":"2023-04-28","current":19.428023,"twenty":-24.131516,"median":22.133715,"eighty":43.587843,"marketCap":142038275000},{"date":"2023-05-05","current":19.201013,"twenty":-24.131516,"median":22.049255,"eighty":42.979111,"marketCap":140378605761},{"date":"2023-05-12","current":19.850434,"twenty":-24.131516,"median":21.75269,"eighty":40.909864,"marketCap":145126520293},{"date":"2023-05-19","current":18.879176,"twenty":-24.131516,"median":21.57897,"eighty":40.438819,"marketCap":138025656966},{"date":"2023-05-26","current":18.551592,"twenty":-24.131516,"median":21.441842,"eighty":40.037509,"marketCap":135630691229},{"date":"2023-06-02","current":18.586075,"twenty":-24.131516,"median":21.323413,"eighty":39.672401,"marketCap":135882792885},{"date":"2023-06-09","current":18.767108,"twenty":-24.131516,"median":21.067856,"eighty":39.30989,"marketCap":137206326582},{"date":"2023-06-16","current":18.583201,"twenty":-24.131516,"median":20.924495,"eighty":38.76535,"marketCap":135861784414},{"date":"2023-06-23","current":18.764234,"twenty":-24.14085,"median":20.774901,"eighty":37.956903,"marketCap":137185318111},{"date":"2023-06-30","current":18.390674,"twenty":-24.150185,"median":19.657906,"eighty":36.490198,"marketCap":134454216832},{"date":"2023-07-07","current":18.229755,"twenty":-24.150185,"median":19.568826,"eighty":35.727263,"marketCap":133277742434},{"date":"2023-07-14","current":17.896425,"twenty":-24.150185,"median":19.258484,"eighty":33.43663,"marketCap":130840759754},{"date":"2023-07-21","current":18.324582,"twenty":-24.15952,"median":19.11768,"eighty":31.771888,"marketCap":133971021990},{"date":"2023-07-28","current":15.932591,"twenty":-24.15952,"median":18.915095,"eighty":27.682522,"marketCap":126871220392},{"date":"2023-08-04","current":16.063766,"twenty":-24.15952,"median":18.814521,"eighty":27.240851,"marketCap":127915771852},{"date":"2023-08-11","current":16.079507,"twenty":-24.15952,"median":18.65504,"eighty":26.887057,"marketCap":128041118028},{"date":"2023-08-18","current":16.30513,"twenty":-24.15952,"median":18.600443,"eighty":26.661838,"marketCap":129837746540},{"date":"2023-08-25","current":16.076884,"twenty":-24.15952,"median":18.534351,"eighty":26.588154,"marketCap":128020226998},{"date":"2023-09-01","current":16.173954,"twenty":-24.15952,"median":18.403605,"eighty":26.567923,"marketCap":128793195079},{"date":"2023-09-08","current":15.733204,"twenty":-24.15952,"median":18.315962,"eighty":26.505248,"marketCap":125283502172},{"date":"2023-09-15","current":15.607275,"twenty":-24.15952,"median":17.92516,"eighty":26.451358,"marketCap":124280732770},{"date":"2023-09-22","current":15.499711,"twenty":-24.15952,"median":17.785793,"eighty":26.356016,"marketCap":123424200572},{"date":"2023-09-29","current":15.253101,"twenty":-24.15952,"median":17.14351,"eighty":26.308627,"marketCap":121460443826},{"date":"2023-10-06","current":14.801857,"twenty":-24.15952,"median":16.994886,"eighty":26.256528,"marketCap":117867186802},{"date":"2023-10-13","current":14.759881,"twenty":-24.15952,"median":16.912197,"eighty":26.215546,"marketCap":117532930335},{"date":"2023-10-20","current":14.817598,"twenty":-24.15952,"median":16.861517,"eighty":26.181912,"marketCap":117992532978},{"date":"2023-10-27","current":13.009187,"twenty":-24.15952,"median":16.75383,"eighty":26.13539,"marketCap":107781117593},{"date":"2023-11-03","current":12.557292,"twenty":-24.15952,"median":16.645066,"eighty":26.102322,"marketCap":104037163348},{"date":"2023-11-10","current":12.380463,"twenty":-24.15952,"median":16.606678,"eighty":26.050188,"marketCap":102572137774},{"date":"2023-11-17","current":12.486069,"twenty":-24.15952,"median":16.545514,"eighty":25.981328,"marketCap":103447083603},{"date":"2023-11-24","current":12.220826,"twenty":-24.15952,"median":16.468598,"eighty":25.948631,"marketCap":101249545241},{"date":"2023-12-01","current":12.1275,"twenty":-24.15952,"median":16.323182,"eighty":25.871656,"marketCap":100476337299},{"date":"2023-12-08","current":12.319064,"twenty":-24.15952,"median":16.284141,"eighty":25.822267,"marketCap":102063448338},{"date":"2023-12-15","current":12.640794,"twenty":-24.15952,"median":16.244457,"eighty":25.741743,"marketCap":104728980980},{"date":"2023-12-22","current":12.589219,"twenty":-24.15952,"median":16.206012,"eighty":25.671391,"marketCap":104301681854},{"date":"2023-12-29","current":12.579395,"twenty":-24.15952,"median":16.17133,"eighty":25.63392,"marketCap":104220291545},{"date":"2024-01-05","current":12.780784,"twenty":-24.15952,"median":16.126731,"eighty":25.574657,"marketCap":105888792893},{"date":"2024-01-12","current":12.3338,"twenty":-24.15952,"median":16.052442,"eighty":25.53878,"marketCap":102185533803},{"date":"2024-01-19","current":12.301873,"twenty":-24.15952,"median":15.981387,"eighty":25.384604,"marketCap":101921015296},{"date":"2024-01-26","current":12.183987,"twenty":-24.15952,"median":15.915318,"eighty":25.326357,"marketCap":100944331580},{"date":"2024-02-02","current":11.953127,"twenty":-24.15952,"median":15.848219,"eighty":25.326357,"marketCap":99031659303},{"date":"2024-02-09","current":12.350536,"twenty":-24.15952,"median":15.711339,"eighty":25.326357,"marketCap":99113049612},{"date":"2024-02-16","current":12.458223,"twenty":-24.15952,"median":15.581954,"eighty":25.326357,"marketCap":99977242239},{"date":"2024-02-23","current":12.934478,"twenty":-24.15952,"median":15.510205,"eighty":25.326357,"marketCap":103799187786},{"date":"2024-03-01","current":12.788326,"twenty":-24.15952,"median":15.476991,"eighty":25.323432,"marketCap":102626315608},{"date":"2024-03-08","current":13.425852,"twenty":-24.15952,"median":15.421006,"eighty":25.323432,"marketCap":107742464938},{"date":"2024-03-15","current":13.226783,"twenty":-24.15952,"median":15.29517,"eighty":25.323432,"marketCap":106144932143},{"date":"2024-03-22","current":12.999995,"twenty":-24.15952,"median":15.228111,"eighty":25.323432,"marketCap":104324958073},{"date":"2024-03-28","current":13.418293,"twenty":-24.15952,"median":15.187513,"eighty":25.323432,"marketCap":107681799135},{"date":"2024-04-05","current":12.981358,"twenty":-24.15952,"median":15.120443,"eighty":25.326357,"marketCap":104175397951},{"date":"2024-04-12","current":12.405531,"twenty":-24.15952,"median":15.050664,"eighty":25.326357,"marketCap":99554388080},{"date":"2024-04-19","current":12.198436,"twenty":-24.15952,"median":15.01354,"eighty":25.326357,"marketCap":97892445934},{"date":"2024-04-26","current":-14.73835,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":90611374291},{"date":"2024-05-03","current":-14.408633,"twenty":-24.15952,"median":14.996944,"eighty":25.323432,"marketCap":88584274195},{"date":"2024-05-10","current":-14.751538,"twenty":-24.15952,"median":14.897686,"eighty":25.323432,"marketCap":90692458295},{"date":"2024-05-17","current":-14.543817,"twenty":-24.15952,"median":14.883186,"eighty":25.323432,"marketCap":89415385234},{"date":"2024-05-24","current":-13.696444,"twenty":-24.15952,"median":14.851704,"eighty":25.323432,"marketCap":84205737987},{"date":"2024-05-31","current":-13.271109,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":81590778864},{"date":"2024-06-07","current":-13.478831,"twenty":-24.15952,"median":14.843629,"eighty":25.323432,"marketCap":82867851924},{"date":"2024-06-14","current":-13.676661,"twenty":-24.15952,"median":14.80891,"eighty":25.326357,"marketCap":84084111982},{"date":"2024-06-21","current":-13.531586,"twenty":-24.15952,"median":14.706868,"eighty":25.329282,"marketCap":83192187939},{"date":"2024-06-28","current":-13.686553,"twenty":-24.161675,"median":14.733375,"eighty":25.346437,"marketCap":84144924984},{"date":"2024-07-05","current":-13.208463,"twenty":-24.161675,"median":14.649759,"eighty":25.346437,"marketCap":81205629845},{"date":"2024-07-12","current":-13.435968,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82604328912},{"date":"2024-07-15","current":-13.34035,"twenty":-24.161675,"median":14.578971,"eighty":25.346437,"marketCap":82016469884},{"date":"2024-08-02","current":-14.930382,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97659625724},{"date":"2024-08-09","current":-14.521245,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":94983464089},{"date":"2024-08-16","current":-15.221736,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99565377191},{"date":"2024-08-23","current":-14.759908,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":96544558376},{"date":"2024-08-30","current":-15.410807,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100802088250},{"date":"2024-09-06","current":-15.435603,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":100964279864},{"date":"2024-09-13","current":-14.952078,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":97801543386},{"date":"2024-09-20","current":-15.193841,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":99382911625},{"date":"2024-09-27","current":-15.534788,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":101613046321},{"date":"2024-10-04","current":-16.799391,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":109884818647},{"date":"2024-10-11","current":-16.241478,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":106235507327},{"date":"2024-10-18","current":-16.48324,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107816875566},{"date":"2024-10-25","current":-16.402653,"twenty":-24.197578,"median":14.814975,"eighty":25.39607,"marketCap":107289752819},{"date":"2024-10-31","current":-16.322065,"twenty":-24.197578,"median":14.812351,"eighty":25.39607,"marketCap":106762630073},{"date":"2024-11-08","current":-15.288171,"twenty":-24.199732,"median":13.697044,"eighty":25.3977,"marketCap":110961545834},{"date":"2024-11-15","current":-16.347249,"twenty":-24.199732,"median":13.400607,"eighty":25.3977,"marketCap":118648335429},{"date":"2024-11-22","current":-16.2718,"twenty":-24.199732,"median":13.207884,"eighty":25.3977,"marketCap":118100727727},{"date":"2024-11-29","current":-16.548446,"twenty":-24.199732,"median":13.07937,"eighty":25.3977,"marketCap":120108622634},{"date":"2024-12-06","current":-16.442259,"twenty":-24.199732,"median":13.01341,"eighty":25.3977,"marketCap":119337915498},{"date":"2024-12-13","current":-15.726892,"twenty":-24.199732,"median":12.968664,"eighty":25.320507,"marketCap":114145783212},{"date":"2024-12-20","current":-15.732481,"twenty":-24.199732,"median":12.88985,"eighty":25.094333,"marketCap":114186346746},{"date":"2024-12-27","current":-16.207529,"twenty":-24.199732,"median":12.836673,"eighty":24.91965,"marketCap":117634247092},{"date":"2025-01-03","current":-15.869407,"twenty":-24.199732,"median":12.825525,"eighty":24.830114,"marketCap":115180153316},{"date":"2025-01-10","current":-15.874995,"twenty":-24.201887,"median":12.736577,"eighty":24.700357,"marketCap":115220716849},{"date":"2025-01-17","current":-15.754836,"twenty":-24.201887,"median":12.665354,"eighty":24.382395,"marketCap":114348600880},{"date":"2025-01-24","current":-16.526091,"twenty":-24.201887,"median":12.629443,"eighty":24.315777,"marketCap":119946368500},{"date":"2025-01-31","current":-16.526091,"twenty":-24.201887,"median":12.589219,"eighty":24.176109,"marketCap":119946368500},{"date":"2025-02-07","current":-16.045454,"twenty":-24.201887,"median":12.557292,"eighty":24.139507,"marketCap":116457904621},{"date":"2025-02-14","current":-12.693406,"twenty":-24.201887,"median":12.48999,"eighty":24.058649,"marketCap":113580593927},{"date":"2025-02-21","current":-12.652584,"twenty":-24.201887,"median":12.441862,"eighty":24.03394,"marketCap":113215317763},{"date":"2025-02-28","current":-13.33522,"twenty":-24.201887,"median":12.405023,"eighty":23.957965,"marketCap":119323546952},{"date":"2025-03-07","current":-13.648189,"twenty":-24.204041,"median":12.35322,"eighty":23.91379,"marketCap":122123997544},{"date":"2025-03-14","current":-13.670868,"twenty":-24.204041,"median":12.333293,"eighty":23.792996,"marketCap":122326928746},{"date":"2025-03-21","current":-13.702619,"twenty":-24.204041,"median":12.308013,"eighty":23.674229,"marketCap":122611032429},{"date":"2025-03-28","current":-13.357899,"twenty":-24.204041,"median":12.274857,"eighty":23.602452,"marketCap":119526478154},{"date":"2025-04-04","current":-13.14819,"twenty":-24.204041,"median":12.234334,"eighty":23.545063,"marketCap":117650007992},{"date":"2025-04-11","current":-11.474536,"twenty":-24.201887,"median":12.193385,"eighty":23.482347,"marketCap":102674150870},{"date":"2025-04-17","current":-11.224398,"twenty":-24.201887,"median":12.165443,"eighty":23.454761,"marketCap":100435911354},{"date":"2025-04-25","current":18.285308,"twenty":-24.204041,"median":12.026806,"eighty":23.356243,"marketCap":99088084638},{"date":"2025-05-02","current":18.63081,"twenty":-24.204041,"median":12.026806,"eighty":23.317376,"marketCap":100960358984},{"date":"2025-05-09","current":17.605571,"twenty":-24.204041,"median":12.026806,"eighty":23.272318,"marketCap":95404588372},{"date":"2025-05-16","current":17.203737,"twenty":-24.204041,"median":12.026806,"eighty":23.222393,"marketCap":93227051906},{"date":"2025-05-23","current":17.661903,"twenty":-24.204041,"median":12.026806,"eighty":23.160274,"marketCap":95709850494},{"date":"2025-05-30","current":17.96985,"twenty":-24.204041,"median":12.026806,"eighty":23.102683,"marketCap":97378616758},{"date":"2025-06-06","current":17.966094,"twenty":-24.204041,"median":12.026806,"eighty":23.03988,"marketCap":97358265950},{"date":"2025-06-13","current":19.036399,"twenty":-24.204041,"median":12.026806,"eighty":23.001392,"marketCap":103158246258},{"date":"2025-06-20","current":17.590549,"twenty":-24.206195,"median":12.014526,"eighty":22.956332,"marketCap":95323185140},{"date":"2025-06-27","current":17.519195,"twenty":-24.206195,"median":12.014526,"eighty":22.892874,"marketCap":94936519786},{"date":"2025-07-03","current":17.620593,"twenty":-24.206195,"median":12.014526,"eighty":22.817575,"marketCap":95485991605},{"date":"2025-07-11","current":18.221465,"twenty":-24.206195,"median":12.014526,"eighty":22.701406,"marketCap":98742120901},{"date":"2025-07-18","current":18.048714,"twenty":-24.206195,"median":12.014526,"eighty":22.649775,"marketCap":97805983728},{"date":"2025-07-25","current":18.379194,"twenty":-24.206195,"median":12.014526,"eighty":22.556783,"marketCap":99596854841},{"date":"2025-08-01","current":17.456793,"twenty":-24.206195,"median":12.014526,"eighty":22.431005,"marketCap":88139349881},{"date":"2025-08-08","current":18.286268,"twenty":-24.177472,"median":12.08226,"eighty":22.400619,"marketCap":92327369611},{"date":"2025-08-15","current":19.273953,"twenty":-24.112846,"median":12.183987,"eighty":22.400619,"marketCap":97314187414},{"date":"2025-08-22","current":19.523897,"twenty":-24.0554,"median":12.220826,"eighty":22.400619,"marketCap":98576157634}],"updateTime":1756076330616},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMY\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2559609951","title":"Cantor Fitzgerald Adjusts Price Target on Bristol-Myers Squibb to $45 From $55, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2559609951","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559609951?lang=en_us&edition=fundamental","pubTime":"2025-08-13 19:08","pubTimestamp":1755083303,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company (BMY) has an average rating of hold and mean price target of $52.35, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research f","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMY"],"gpt_icon":0},{"id":"2559208679","title":"Evotec SE Reports H1 2025 Results: Consolidated Revenues Down 5% to €371.2M, Adjusted EBITDA at -€1.9M, Just - Evotec Biologics Sales Up 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2559208679","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559208679?lang=en_us&edition=fundamental","pubTime":"2025-08-13 13:02","pubTimestamp":1755061374,"startTime":"0","endTime":"0","summary":"Evotec SE Reports H1 2025 Results: Consolidated Revenues Down 5% to 371.2M, Adjusted EBITDA at -1.9M, Just - Evotec Biologics Sales Up 16%. Evotec SE has announced its financial results for the first half of 2025, highlighting significant progress in strategy implementation for sustainable and profitable growth. The company reported a consolidated revenue of 371.2 million, representing a 5% decrease. The Discovery & Preclinical Development  segment experienced an 11% decline in demand, while Just - Evotec Biologics  exceeded expectations with a 16% increase in revenues to 102.2 million, driven by an expanded customer base. The adjusted consolidated EBITDA stood at -1.9 million, aligning with expectations due to effective cost control measures across the organization. The company has made decisive advancements in its collaborations, notably with Bristol Myers Squibb in targeted protein degradation and neurology, and announced a significant development in its strategic partnership with S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL1QWG88:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY"],"gpt_icon":0},{"id":"2559291266","title":"Editas Medicine's CD19 HD Allo CAR T Program Receives IND/CTA Acceptance, Secures Milestone Payment Through Collaboration with Bristol Myers Squibb","url":"https://stock-news.laohu8.com/highlight/detail?id=2559291266","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559291266?lang=en_us&edition=fundamental","pubTime":"2025-08-13 04:04","pubTimestamp":1755029081,"startTime":"0","endTime":"0","summary":"Editas Medicine's CD19 HD Allo CAR T Program Receives IND/CTA Acceptance, Secures Milestone Payment Through Collaboration with Bristol Myers Squibb. Editas Medicine Inc., a pioneering gene editing company, has announced a significant milestone in its collaboration with Bristol Myers Squibb. The company has successfully secured its first IND/CTA acceptance for the CD19 HD Allo CAR T program, marking a crucial step forward in their joint efforts. This acceptance has also triggered a milestone payment to Editas, highlighting the progress and potential of their collaborative program. This development is part of Editas' broader strategy to advance transformative medicines for serious diseases and underscores their ongoing commitment to innovation in gene editing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250812:nNDL5LXS2q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE0009355771.USD","BK4139","LU1571399168.USD","LU0061475181.USD","BK4534","LU0321505439.SGD","LU0096364046.USD","LU0237698245.USD","LU1430594728.SGD","LU1323610961.USD","LU1670710588.SGD","EDIT","LU1868837300.USD","LU2133065610.SGD","LU1670711123.USD","IE00BFTCPJ56.SGD","LU1868836757.USD","LU1989771016.USD","LU0306806265.USD","LU1093756168.USD","LU0882574055.USD","IE0002141913.USD","LU2242646821.SGD","LU2360032135.SGD","LU1670711040.USD","BMY","LU0985481810.HKD","IE00BFXG1179.USD","BK4588","LU2242652126.USD","BK4532","LU1670710661.SGD","IE00BSNM7G36.USD","LU0321505868.SGD","LU1868837136.USD","LU1261432733.SGD","LU1585245621.USD","BK4556","LU1093756325.SGD","LU0306807586.USD","LU1868836914.USD","LU1291159041.SGD","BK4007","BK4559","LU0114720955.EUR","LU0225284248.USD","LU1718418525.SGD","LU0267386448.USD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2558628078","title":"Bloomsbury Executives Sell Shares Post-Vesting to Cover Liabilities","url":"https://stock-news.laohu8.com/highlight/detail?id=2558628078","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558628078?lang=en_us&edition=fundamental","pubTime":"2025-08-12 23:32","pubTimestamp":1755012744,"startTime":"0","endTime":"0","summary":"Bloomsbury Publishing ( ($GB:BMY) ) has shared an announcement. Bloomsbury Publishing announced the sale of shares by its Chief Executive, Nigel Ne...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bloomsbury-executives-sell-shares-post-vesting-to-cover-liabilities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bloomsbury-executives-sell-shares-post-vesting-to-cover-liabilities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU1670711040.USD","LU1718418525.SGD","LU0237698245.USD","LU1291159041.SGD","LU0096364046.USD","LU0225284248.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0267386448.USD","LU1670711123.USD","BK4007","LU0321505439.SGD","BMY","IE00BJT1NW94.SGD","LU1261432733.SGD","LU2133065610.SGD","LU1074936037.SGD","LU1868836757.USD","LU1093756325.SGD","IE0002141913.USD","LU0114720955.EUR","BK4588","LU1093756168.USD","BK4585","LU0456855351.SGD","LU1571399168.USD","LU1868836591.USD","LU1868837136.USD","LU2242652126.USD","LU1430594728.SGD","LU0061475181.USD","LU1670710661.SGD","LU2125154935.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","BK4212","LU0225771236.USD","LU0985481810.HKD","LU0306807586.USD","BK4581","BK4534","IE00BFXG1179.USD","LU0321505868.SGD","LU0868494617.USD","POST","BK4532","LU1032466523.USD","BK4559","LU0306806265.USD"],"gpt_icon":0},{"id":"2558464506","title":"Market Chatter: Eli Lilly, Pfizer Among Drugmakers Eyeing a Spot in Chinese Commercial Health Insurance Catalog","url":"https://stock-news.laohu8.com/highlight/detail?id=2558464506","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558464506?lang=en_us&edition=fundamental","pubTime":"2025-08-12 18:41","pubTimestamp":1754995282,"startTime":"0","endTime":"0","summary":"Eli Lilly , Pfizer , Novo Nordisk , and Biogen  are among a number of Western pharmaceutical companies that have applied for their drugs and treatments to be included in China's new catalog of commercial health insurance, Bloomberg reported Tuesday.The list includes Alzheimer's therapies from Eli Lilly, cancer treatments from Bristol-Myers Squibb , and an oral diabetes drug from Novo Nordisk. Other companies that featured in the list included Gilead Sciences , Johnson & Johnson , and AstraZeneca , the report said.A total of 121 drugs passed the preliminary evaluation, and a final decision is expected by October or November, the report added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1057294990.SGD","PFE","LU1074936037.SGD","LU2089984988.USD","LU0985481810.HKD","LU1894683348.USD","LU1983299246.USD","NVO","BK4566","IE00B2B36J28.USD","LU1868836591.USD","SGXZ99366536.SGD","LU0321505439.SGD","LU2347655156.SGD","BIIB","LU2430703251.USD","JNJ","IE00BFTCPJ56.SGD","SG9999014898.SGD","LU2133065610.SGD","LU1868837300.USD","LU2462157665.USD","PFE.AU","LLY","LU0203201768.USD","SG9999013999.USD","IE00BBT3K403.USD","LU0109391861.USD","IE00BLSP4452.SGD","LU0820561909.HKD","SG9999015952.SGD","SG9999017495.SGD","SG9999011175.SGD","IE00B42XCP33.USD","LU0354030511.USD","LU0234572021.USD","LU2360106947.USD","IE00BJLML261.HKD","LU0943347566.SGD","LU2491050071.SGD","LU1674673428.USD","AZN","LU0238689110.USD","LU2129689431.USD","BMY","GILD","LU1674673691.USD","LU1032955483.USD","LU2430703178.SGD","NVO.AU"],"gpt_icon":1},{"id":"2558643794","title":"Bristol-Myers Squibb (BMY) Receives a Buy from Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2558643794","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558643794?lang=en_us&edition=fundamental","pubTime":"2025-08-12 17:35","pubTimestamp":1754991336,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst David Amsellem maintained a Buy rating on Bristol-Myers Squibb yesterday and set a price target of $64.00. The company’s shar...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bristol-myers-squibb-bmy-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bristol-myers-squibb-bmy-receives-a-buy-from-piper-sandler-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1670710661.SGD","LU1868837300.USD","IE00B2B36J28.USD","LU1670711123.USD","IE00BFXG1179.USD","LU0321505439.SGD","BK4532","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1670710588.SGD","BK4581","LU2133065610.SGD","LU1074936037.SGD","IE0002141913.USD","LU1261432733.SGD","LU1868836914.USD","BK4588","LU0456855351.SGD","LU2360032135.SGD","LU2125154778.USD","LU1032466523.USD","LU0237698245.USD","IE00BSNM7G36.USD","BK4534","LU1989771016.USD","BMY","BK4559","BK4585","LU0267386448.USD","LU2242646821.SGD","LU0985481810.HKD","LU1291159041.SGD","LU1868837136.USD","LU1670711040.USD","LU1868836757.USD","LU0061475181.USD","LU0306806265.USD","LU1093756168.USD","LU0225771236.USD","LU1718418525.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU1323610961.USD","LU1093756325.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU0225284248.USD","LU0321505868.SGD","LU0096364046.USD","BK4007"],"gpt_icon":0},{"id":"2558659387","title":"Bloomsbury Publishing Announces Share Awards Vesting","url":"https://stock-news.laohu8.com/highlight/detail?id=2558659387","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558659387?lang=en_us&edition=fundamental","pubTime":"2025-08-11 18:14","pubTimestamp":1754907276,"startTime":"0","endTime":"0","summary":"Bloomsbury Publishing ( ($GB:BMY) ) just unveiled an update. Bloomsbury Publishing PLC announced the vesting and exercise of awards under its 2014 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bloomsbury-publishing-announces-share-awards-vesting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bloomsbury-publishing-announces-share-awards-vesting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242646821.SGD","LU2125154778.USD","LU1718418525.SGD","IE00BSNM7G36.USD","LU0237698245.USD","LU1291159041.SGD","LU0225284248.USD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU0267386448.USD","LU1670711123.USD","BK4007","LU0321505439.SGD","BMY","IE00BJT1NW94.SGD","LU1261432733.SGD","LU1868837300.USD","LU2133065610.SGD","LU1868836757.USD","LU1093756325.SGD","IE0002141913.USD","LU0114720955.EUR","BK4588","LU1093756168.USD","BK4585","LU0456855351.SGD","LU1868836591.USD","LU1868837136.USD","LU2360032135.SGD","LU1430594728.SGD","LU0061475181.USD","LU1670710661.SGD","LU1670710588.SGD","LU2125154935.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0225771236.USD","LU0985481810.HKD","LU0306807586.USD","BK4581","BK4534","IE00BFXG1179.USD","LU1868836914.USD","LU0321505868.SGD","BK4532","LU0882574055.USD","LU1032466523.USD","BK4559","LU0306806265.USD","LU1989771016.USD"],"gpt_icon":0},{"id":"2558041508","title":"4 Stocks That Deliver the Coveted 5% Yield -- Barron's","url":"https://stock-news.laohu8.com/highlight/detail?id=2558041508","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2558041508?lang=en_us&edition=fundamental","pubTime":"2025-08-09 09:30","pubTimestamp":1754703000,"startTime":"0","endTime":"0","summary":"With elevated inflation, income investments that can keep up with the pace of rising prices are crucial. By Ian Salisbury. Investors love dividends. But blue-chip companies that also boast impressive dividend yields -- think 5% or more -- have become an endangered species.Lately, however, the bull market has also played a role. Fast-rising stock prices mean higher price-to-earnings ratios; they also compress dividend yields. For the past year ended June 30, S&P 500 companies increased the amount they spent on dividends by more than 8%, but share prices rose by more than 13%.Like other stocks on our list, Bristol Myers sports a yield that's so high -- 5.4% -- in part because its stock price has fallen so far. Shares have tumbled nearly 20% this year, as investors worry that its drug pipeline lacks potential replacements for aging hits like Eliquis and Opdivo.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["US6M.BOND","LU2458330243.SGD","LU2250418816.HKD","BMY","US12M.BOND","LU2125154778.USD","PRU","IE00B19Z3B42.SGD","LU1674673691.USD","EIX","LU1868837136.USD","SGXZ99366536.SGD","LU2361044865.SGD","SG9999014898.SGD","LU0949170426.SGD","LU2430703251.USD","LU0456855351.SGD","LU1992135399.USD","LU2552382132.HKD","LU2404859667.USD","IE00BMG7P694.USD","LU1868836914.USD","US5Y.BOND","BK4592","US2Y.BOND","LU0868494617.USD","LU2168564065.EUR","LU0225284248.USD","LU0979878070.USD","LU0957808578.USD","US3Y.BOND","US10Y.BOND","LU2860962120.EUR","LU2247934214.USD","LU0072462426.USD","LU1116320737.USD","LU1551013425.SGD","LU1629891620.HKD","LU2417539215.USD","LU1435385759.SGD","US7Y.BOND","LU1066051498.USD","BK4588","LU1803068979.SGD","BK4081","LU1548497426.USD","US30Y.BOND","LU0321505868.SGD","LU2552382058.USD"],"gpt_icon":1},{"id":"2557928635","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2557928635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557928635?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:40","pubTimestamp":1754599200,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  rose 1.20% to $45.36 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.08% to 6,340.00 and Dow Jones Industrial Average  falling 0.51% to 43,968.64.Bristol Myers Squibb Co. closed 28.38% below its 52-week high of $63.33, which the company reached on March 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 0.55% to $171.53, Pfizer Inc.  rose 1.25% to $24.23, and Abbott Laboratories  rose 0.86% to $132.06.Trading volume  remained 2.0 million below its 50-day average volume of 13.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 7, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Str","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2557585537","title":"Prothena Corporation Unveils Presentation on Life-Saving Therapies for Protein Dysregulation Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2557585537","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557585537?lang=en_us&edition=fundamental","pubTime":"2025-08-07 07:20","pubTimestamp":1754522407,"startTime":"0","endTime":"0","summary":"Prothena Corporation plc has released a presentation detailing its focus on delivering life-saving therapies for diseases caused by protein dysregulation, including Alzheimer's disease, Parkinson's disease, and Transthyretin amyloidosis. The presentation highlights the company's multiple ongoing clinical programs, including two partnered Phase 3 programs, one partnered Phase 2 program, one partnered Phase 1 program, and one wholly-owned Phase 1 program. Prothena has established strong collaborations with major companies such as Bristol Myers Squibb, Novo Nordisk, and Roche. The presentation also emphasizes Prothena's expertise in epitope mapping and disease-driven antibody engineering, aiming to optimize therapeutic outcomes for patients. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated cont","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nNDLgPMqZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BMY","LU1670711040.USD","LU1868837136.USD","LU1670711123.USD","BK4534","LU2125154935.USD","LU1585245621.USD","IE00BFTCPJ56.SGD","BK4007","IE00BJJMRZ35.SGD","LU0237698245.USD","LU1074936037.SGD","LU1093756168.USD","LU1868836757.USD","LU0096364046.USD","LU1868836914.USD","LU0225771236.USD","BK4139","LU0868494617.USD","LU0321505439.SGD","LU2125154778.USD","IE0002141913.USD","LU0321505868.SGD","LU0882574055.USD","LU1670710588.SGD","BK4559","LU2360032135.SGD","BK4588","LU0267386448.USD","BK4581","IE00BSNM7G36.USD","LU0306806265.USD","BK4532","LU1093756325.SGD","LU1323610961.USD","LU1718418525.SGD","LU1868836591.USD","LU1989771016.USD","PRTA","LU0306807586.USD","LU2133065610.SGD","LU2242652126.USD","LU1032466523.USD","LU1571399168.USD","LU0114720955.EUR","IE0009355771.USD","IE00B2B36J28.USD","LU0456855351.SGD","LU0225284248.USD"],"gpt_icon":0},{"id":"2557317284","title":"Bristol-Myers Squibb Files Initial Ownership Statement for EVP Cristian Massacesi","url":"https://stock-news.laohu8.com/highlight/detail?id=2557317284","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557317284?lang=en_us&edition=fundamental","pubTime":"2025-08-06 06:15","pubTimestamp":1754432143,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company has filed an initial statement of beneficial ownership with the United States Securities and Exchange Commission. The filing identifies Cristian Massacesi as the beneficial owner, serving in the role of Executive Vice President, Chief Medical Officer, and Head of Development. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL6w5Kcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0456855351.SGD","BK4581","IE0009355771.USD","LU1571399168.USD","LU1868836591.USD","LU0061475181.USD","BK4534","LU0321505439.SGD","LU0096364046.USD","LU1430594728.SGD","LU1323610961.USD","LU1670710588.SGD","LU0225771236.USD","LU1868837300.USD","LU2133065610.SGD","LU1670711123.USD","IE00BFTCPJ56.SGD","LU1989771016.USD","LU0306806265.USD","LU1093756168.USD","LU2125154778.USD","IE0002141913.USD","LU2242646821.SGD","LU2360032135.SGD","LU1670711040.USD","BMY","IE00BJJMRZ35.SGD","LU0985481810.HKD","IE00BFXG1179.USD","BK4588","LU2242652126.USD","BK4532","LU2125154935.USD","IE00B2B36J28.USD","LU1670710661.SGD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","LU0321505868.SGD","LU1868837136.USD","LU1261432733.SGD","LU1585245621.USD","LU1093756325.SGD","LU1868836914.USD","LU1291159041.SGD","BK4007","BK4559","LU0114720955.EUR","LU0225284248.USD","LU1718418525.SGD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2557131796","title":"Wendy Short Bartie, EVP of Corporate Affairs, Reports Disposal of Common Shares in Bristol-Myers Squibb Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2557131796","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557131796?lang=en_us&edition=fundamental","pubTime":"2025-08-06 05:59","pubTimestamp":1754431167,"startTime":"0","endTime":"0","summary":"Wendy Short Bartie, EVP of Corporate Affairs at Bristol-Myers Squibb Company, reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bristol-Myers Squibb Company published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on August 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL2ZY0ww:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670710588.SGD","BK4534","BK4532","LU0321505868.SGD","LU1670711123.USD","LU0868494617.USD","LU1585245621.USD","LU2242646821.SGD","LU1868837136.USD","IE0009355771.USD","LU1868836914.USD","LU1989771016.USD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0096364046.USD","LU1868837300.USD","LU1670711040.USD","LU1261432733.SGD","LU1074936037.SGD","LU2242652126.USD","LU0114720955.EUR","LU0237698245.USD","LU0882574055.USD","LU0985481810.HKD","LU1571399168.USD","LU1868836757.USD","LU2360032135.SGD","BMY","LU0225771236.USD","LU0267386448.USD","LU1323610961.USD","IE00BSNM7G36.USD","LU0061475181.USD","IE00BJT1NW94.SGD","BK4581","LU1093756325.SGD","LU0225284248.USD","LU1291159041.SGD","LU2125154935.USD","IE0002141913.USD","LU2133065610.SGD","LU2125154778.USD","BK4007","LU0321505439.SGD","LU1868836591.USD","LU0306807586.USD","LU1670710661.SGD","LU1718418525.SGD","LU1032466523.USD","BK4559"],"gpt_icon":0},{"id":"2557648343","title":"Daiwa Securities Downgrades Bristol-Myers Squibb to Neutral From Outperform, Adjusts PT to $42 From $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2557648343","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557648343?lang=en_us&edition=fundamental","pubTime":"2025-08-05 17:21","pubTimestamp":1754385674,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) has an average rating of hold and mean price target of $52.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from majo","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BMY","PT"],"gpt_icon":0},{"id":"2557331713","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331713","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557331713?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:41","pubTimestamp":1754340060,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  rose 2.65% to $45.40 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.47% to 6,329.94 and the Dow Jones Industrial Average  rising 1.34% to 44,173.64.This was the stock's second consecutive day of gains.Bristol Myers Squibb Co. closed 28.31% below its 52-week high of $63.33, which the company reached on March 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 2.22% to $171.04, Pfizer Inc.  rose 0.17% to $23.53, and Abbott Laboratories  rose 2.07% to $129.93.Trading volume  eclipsed its 50-day average volume of 13.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 4, 2025.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street J","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMY","MYE"],"gpt_icon":0},{"id":"2557310153","title":"Prothena Corporation plc Unveils Presentation Highlighting Advances in Life-Saving Therapies for Neurodegenerative Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2557310153","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557310153?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:25","pubTimestamp":1754339148,"startTime":"0","endTime":"0","summary":"Prothena Corporation plc has released a presentation detailing its ongoing efforts in developing life-saving therapies targeting diseases of protein dysregulation such as Alzheimer's disease, Parkinson's disease, and Transthyretin amyloidosis. The presentation highlights the significant global impact of these conditions, with over 80 million people worldwide living with early symptomatic Alzheimer's and more than 10 million affected by Parkinson's disease. Prothena's strategic collaborations with companies like Bristol Myers Squibb, Novo Nordisk, and Roche are underscored, as well as its various clinical programs, including one partnered Phase 3 program and multiple Phase 1 and 2 programs. The company emphasizes its expert epitope mapping and disease-driven antibody engineering to target proteins with the greatest effect on disease. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial int","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL2HF6X9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989771016.USD","LU1571399168.USD","LU1323610961.USD","BK4534","IE00BJJMRZ35.SGD","LU2242652126.USD","LU1585245621.USD","LU0456855351.SGD","BK4581","LU1868836914.USD","LU2125154935.USD","IE00BJT1NW94.SGD","LU0061475181.USD","LU1074936037.SGD","PRTA","BK4139","LU0868494617.USD","LU0225284248.USD","IE00B2B36J28.USD","IE0002141913.USD","LU0306807586.USD","LU1291159041.SGD","LU2360032135.SGD","LU1093756325.SGD","LU0321505868.SGD","LU1261432733.SGD","LU1430594728.SGD","LU2125154778.USD","LU0306806265.USD","LU1670711040.USD","LU0985481810.HKD","LU1670711123.USD","BMY","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","LU0237698245.USD","LU1670710661.SGD","LU0225771236.USD","LU0321505439.SGD","LU1868836757.USD","BK4007","LU2133065610.SGD","BK4585","BK4588","LU0882574055.USD","BK4532","IE0009355771.USD","LU1032466523.USD","LU0114720955.EUR","LU0096364046.USD"],"gpt_icon":0},{"id":"2557331658","title":"Bristol Myers Squibb's Breyanzi CAR T Cell Therapy for Marginal Zone Lymphoma Under Priority Review by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331658","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557331658?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:16","pubTimestamp":1754338599,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration  has accepted its supplemental biologics license application  for Breyanzi  under Priority Review. This application aims to expand the use of Breyanzi as a treatment for adult patients with relapsed or refractory marginal zone lymphoma  who have received at least two prior lines of systemic therapy. If approved, Breyanzi would become the first and only CAR T cell therapy available for MZL, addressing a high unmet medical need. The FDA has set a Prescription Drug User Fee Act  goal date of December 5, 2025, for the review completion. This milestone reflects BMS's ongoing efforts to enhance access to innovative cell therapies for cancer patients.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nNDL9QpD33:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","BK4588","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU0985481810.HKD","IE0009355771.USD","LU1670710661.SGD","LU0225771236.USD","BK4532","LU0306807586.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU1032466523.USD","LU1571399168.USD","LU1670711123.USD","LU2125154778.USD","LU0321505439.SGD","LU1868836757.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU2125154935.USD","LU1261432733.SGD","LU1074936037.SGD","LU0096364046.USD","LU0456855351.SGD","LU0321505868.SGD","LU2242652126.USD","IE0002141913.USD","LU1868836914.USD","LU1670711040.USD","BK4534","LU0225284248.USD","LU1868836591.USD","LU1291159041.SGD","BK4007","IE00B2B36J28.USD","LU1093756168.USD","LU2242646821.SGD","LU1093756325.SGD","BMY","BK4585","LU0868494617.USD","LU2133065610.SGD","LU0114720955.EUR","LU1323610961.USD","LU1585245621.USD","BK4581"],"gpt_icon":0},{"id":"2557806331","title":"Bristol-Myers Squibb Co - FDA Sets Pdufa Goal Date for Breyanzi on Dec 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2557806331","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557806331?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:16","pubTimestamp":1754338560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA44QYQ1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0061475181.USD","BK4581","LU0321505439.SGD","BK4007","LU2242652126.USD","BK4534","LU2125154778.USD","LU0456855351.SGD","LU1571399168.USD","LU0868494617.USD","LU0225284248.USD","BK4585","LU0225771236.USD","IE00BFXG1179.USD","LU0882574055.USD","LU1670711040.USD","LU0306807586.USD","BK4588","IE00BFTCPJ56.SGD","BK4532","LU0114720955.EUR","IE00B2B36J28.USD","LU1032466523.USD","LU0321505868.SGD","LU0985481810.HKD","LU1868836914.USD","LU1261432733.SGD","LU1718418525.SGD","LU1093756168.USD","LU1074936037.SGD","LU1093756325.SGD","LU1868837300.USD","LU1323610961.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU0096364046.USD","BMY","LU1868836591.USD","IE0002141913.USD","LU1868836757.USD","LU2133065610.SGD","LU1670710661.SGD","LU0237698245.USD","LU1670711123.USD","LU2242646821.SGD","LU1291159041.SGD","BK4559","LU2360032135.SGD","LU1868837136.USD"],"gpt_icon":0},{"id":"2557331837","title":"Bristol Myers Squibb’s Application for Breyanzi (Lisocabtagene Maraleucel) Accepted for Priority Review by U.S. Food and Drug Administration (FDA) in Fifth Cancer Type for Relapsed or Refractory Marginal Zone Lymphoma (Mzl)","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331837","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557331837?lang=en_us&edition=fundamental","pubTime":"2025-08-05 04:16","pubTimestamp":1754338560,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nTUA44QYQ1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4559","LU0225284248.USD","LU1261432733.SGD","BK4007","LU1430594728.SGD","LU1868836914.USD","LU1868836757.USD","LU2133065610.SGD","LU0306807586.USD","LU1670711040.USD","LU1670710661.SGD","IE00B2B36J28.USD","LU1868837300.USD","BK4585","LU1032466523.USD","LU0096364046.USD","IE0002141913.USD","LU1571399168.USD","LU0985481810.HKD","LU1074936037.SGD","LU2360032135.SGD","LU1670711123.USD","BK4534","LU2125154778.USD","LU2242646821.SGD","LU2242652126.USD","LU0225771236.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","BK4532","BMY","LU1323610961.USD","LU1718418525.SGD","LU1868836591.USD","LU0868494617.USD","LU0456855351.SGD","LU1093756168.USD","LU0237698245.USD","LU1093756325.SGD","LU0882574055.USD","LU1868837136.USD","IE00BFTCPJ56.SGD","BK4588","BK4581","IE00BJJMRZ35.SGD","LU1291159041.SGD","IE00BFXG1179.USD","LU0321505868.SGD","LU0114720955.EUR","LU0061475181.USD"],"gpt_icon":0},{"id":"2557333367","title":"Bristol-Myers Squibb’s New Study on Schizophrenia Treatment Satisfaction","url":"https://stock-news.laohu8.com/highlight/detail?id=2557333367","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557333367?lang=en_us&edition=fundamental","pubTime":"2025-08-05 00:06","pubTimestamp":1754323603,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb Company is conducti...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-new-study-on-schizophrenia-treatment-satisfaction?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-new-study-on-schizophrenia-treatment-satisfaction?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2242652126.USD","BK4007","LU0868494617.USD","IE00BSNM7G36.USD","LU1032466523.USD","LU1430594728.SGD","LU1670710588.SGD","LU1571399168.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","LU1261432733.SGD","LU0061475181.USD","LU0456855351.SGD","IE0002141913.USD","BK4585","LU0114720955.EUR","LU0985481810.HKD","BK4559","LU1670711123.USD","BK4532","LU0306806265.USD","IE00BJJMRZ35.SGD","LU1074936037.SGD","LU1093756325.SGD","BMY","LU1291159041.SGD","LU1670711040.USD","LU1989771016.USD","IE00BFXG1179.USD","IE00B2B36J28.USD","LU0225284248.USD","LU1585245621.USD","IE0009355771.USD","LU0306807586.USD","LU0096364046.USD","LU0882574055.USD","LU1868836757.USD","LU1323610961.USD","LU1670710661.SGD","IE00BJT1NW94.SGD","LU1093756168.USD","LU1868836914.USD","LU2242646821.SGD","BK4588","LU1868837300.USD","LU2133065610.SGD","LU1868836591.USD","LU0321505439.SGD","LU0267386448.USD","BK4581"],"gpt_icon":0},{"id":"2557585333","title":"Bristol-Myers Squibb’s New Phase 3 Trial: A Potential Game-Changer in Lung Cancer Treatment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2557585333","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557585333?lang=en_us&edition=fundamental","pubTime":"2025-08-05 00:04","pubTimestamp":1754323481,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. In a recent clinical study update, Bristol-Myers Squibb ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-new-phase-3-trial-a-potential-game-changer-in-lung-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bristol-myers-squibbs-new-phase-3-trial-a-potential-game-changer-in-lung-cancer-treatment?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMY","IE00BJJMRZ35.SGD","LU0225284248.USD","LU0882574055.USD","LU1670711123.USD","LU0456855351.SGD","LU1032466523.USD","LU1585245621.USD","LU1571399168.USD","LU2125154935.USD","LU2133065610.SGD","LU0096364046.USD","IE00BFTCPJ56.SGD","LU0114720955.EUR","LU0321505439.SGD","LU0985481810.HKD","BK4581","LU0061475181.USD","LU2242646821.SGD","LU0306806265.USD","IE00B2B36J28.USD","LU1323610961.USD","IE0002141913.USD","LU1670711040.USD","BK4559","IE00BFXG1179.USD","BK4007","LU1670710588.SGD","LU0868494617.USD","LU1670710661.SGD","LU1261432733.SGD","BK4532","LU1868836914.USD","LU1868836757.USD","LU1868837300.USD","LU1430594728.SGD","LU1074936037.SGD","IE0009355771.USD","LU1291159041.SGD","LU1093756168.USD","BK4585","LU0306807586.USD","LU0267386448.USD","IE00BJT1NW94.SGD","BK4588","LU2242652126.USD","LU1989771016.USD","LU1868836591.USD","LU1093756325.SGD","IE00BSNM7G36.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":2,"totalSize":178,"code":"91000000","status":"200"}]}}